|
Market Cap (18-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
CYP released this announcement to the ASX on 26 July 2021, 11:19. The announcement is not marked as price sensitive, and is 2 page(s) in length and 202.54kb in size.
You can view all announcements from CYP and see how they appear on a price chart on the announcements page.
At the date of this announcement, CYP was 0.001% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 255th most shorted stock on the ASX with 0.624% of total shares short sold as of the latest reported data (10 December 2024).
| Other Recent Announcements from CYP | |
|---|---|
| Notification regarding unquoted securities - CYP | 30 June 2023, 13:10 |
| Proposed issue of securities - CYP | 30 June 2023, 9:44 |
| Cynata announces CEO succession and Board changes | 30 June 2023, 9:13 |
| Cynata Appoints Dr Jolanta Airey Chief Medical Officer | 26 July 2021, 11:19 |
| Change of Registered Office | 5 July 2021, 17:35 |
| Ethics Approval for Cynata's Clinical Trial in DFU | 30 June 2021, 9:49 |
| Progress Toward Clinical Trial in Diabetic Foot Ulcers | 28 June 2021, 9:20 |
You must be logged in to post a reply.
Cynata Therapeutics 